Pendin D

Neuroscience Institute, Italian National Research Council, Padua, Italy; Department of Biomedical Sciences, University of Padua, Padua, Italy.

2 papers

ArticlePsilocybin

Low, non-psychedelic doses of psilocybin as a novel treatment for MASLD, obesity and type 2 diabetes via 5-HT2B receptor-dependent mechanisms.

Colognesi M, Gabbia D, Signor A +30

Europe PMC2026
ArticlePsilocybin

Emerging mechanisms of psilocybin-induced neuroplasticity.

Sonda S, Pendin D, Comai S +3

Europe PMC2025